Search - tctmd.com

Displaying 61 - 80 of 103

Sort: Relevancy | Date

News Conference News VIVA 2017

DCBs, Stents, and ‘Swirling Flow’ Show Promise in Femoropopliteal Disease

L.A. McKeown

September 13, 2017

News Conference News ISET 2017

Underappreciated by Clinicians, Critical Limb Ischemia Has Dire Fallout for Patients

Caitlin E. Cox

February 07, 2017

News Daily News

More Evidence of Comparable Outcomes for Stenting, Surgery in Chronic Limb Ischemia

L.A. McKeown

December 20, 2016

News Conference News AHA 2016

AHA/ACC Issue Updated PAD Guidelines

L.A. McKeown

November 14, 2016

News Conference News VIVA 2016

Longer Term, IN.PACT SFA Trial and Global Registry Continue to Support DCB Therapy as an Option

L.A. McKeown

October 12, 2016

News Conference News VIVA 2016

Long PAD Lesions Respond Well to DCB, but Optimal Patient Selection Still Unclear

L.A. McKeown

September 21, 2016

News Daily News

Potential Benefits of Drug-Coated Balloons for Infrapopliteal Disease Remain Uncertain

Todd Neale

April 28, 2016

News Industry News

CARDIONOVUM Announces Enrollment of First Patient in MAGNIFICENT Trial

April 07, 2016

News Industry News

New Real-World Comparison Showing Similar Efficacy Between the Lutonix® and In.Pact™ Drug-Coated Balloons Featured at LINC 2016

February 08, 2016

News Industry News

Positive Six-Month Tack Optimized Balloon Angioplasty Below-the-Knee (TOBA-BTK) Results Presented at LINC 2016

January 25, 2016

News Conference News VEITH 2015

DCBs for Femoropoliteal Disease: What’s Now and What’s Next?

Yael L. Maxwell

November 19, 2015

News Daily News

More Discouraging News for DCBs in Treatment of Infrapopliteal Lesions

L.A. McKeown

October 26, 2015

News Industry News

Intact Vascular Announces Conditional FDA Approval for Tack Optimized Balloon Angioplasty II (TOBA II) Study and Enrollment of First Patients

September 30, 2015

News Industry News

Spectranetics Completes Enrollment in ILLUMENATE Pivotal Study to Assess Safety and Efficacy of Stellarex(TM) Drug-Coated Balloon Technology

July 29, 2015

News Daily News

LEVANT 2: DCB Beats Standard Balloon Angioplasty at 1 Year in Femoropopliteal Disease

Yael L. Maxwell

June 26, 2015

News Daily News

ISET Abstracts Shed Light on Novel Therapies for PAD

Caitlin E. Cox

February 04, 2015

News Daily News

Drug-Coated Balloon Beats Angioplasty Alone in PAD Patients

Salynn Boyles

December 15, 2014

News Daily News

DCBs Perform Better in De Novo Compared With Restenotic Femoropopliteal Lesions

Caitlin E. Cox

October 24, 2014

Presentation TCT 2014

Unmet Technical Needs and Opportunities for the Development of Next-Generation Technologies

Presenter: Gary M. Ansel, Jihad A. Mustapha, Douglas E. Drachman, Marianne Brodmann

September 15, 2014

Presentation TCT 2014

DCB in BTK Intervention: Ongoing Trials and Future Perspectives

Presenter: Gary M. Ansel, Jihad A. Mustapha, Douglas E. Drachman, Lawrence A. Garcia

September 15, 2014

Advertisement

DCBs, Stents, and ‘Swirling Flow’ Show Promise in Femoropopliteal Disease

Underappreciated by Clinicians, Critical Limb Ischemia Has Dire Fallout for Patients

More Evidence of Comparable Outcomes for Stenting, Surgery in Chronic Limb Ischemia

AHA/ACC Issue Updated PAD Guidelines

Longer Term, IN.PACT SFA Trial and Global Registry Continue to Support DCB Therapy as an Option

Long PAD Lesions Respond Well to DCB, but Optimal Patient Selection Still Unclear

Potential Benefits of Drug-Coated Balloons for Infrapopliteal Disease Remain Uncertain

CARDIONOVUM Announces Enrollment of First Patient in MAGNIFICENT Trial

New Real-World Comparison Showing Similar Efficacy Between the Lutonix® and In.Pact™ Drug-Coated Balloons Featured at LINC 2016

Positive Six-Month Tack Optimized Balloon Angioplasty Below-the-Knee (TOBA-BTK) Results Presented at LINC 2016

DCBs for Femoropoliteal Disease: What’s Now and What’s Next?

More Discouraging News for DCBs in Treatment of Infrapopliteal Lesions

Intact Vascular Announces Conditional FDA Approval for Tack Optimized Balloon Angioplasty II (TOBA II) Study and Enrollment of First Patients

Spectranetics Completes Enrollment in ILLUMENATE Pivotal Study to Assess Safety and Efficacy of Stellarex(TM) Drug-Coated Balloon Technology

LEVANT 2: DCB Beats Standard Balloon Angioplasty at 1 Year in Femoropopliteal Disease

ISET Abstracts Shed Light on Novel Therapies for PAD

Drug-Coated Balloon Beats Angioplasty Alone in PAD Patients

DCBs Perform Better in De Novo Compared With Restenotic Femoropopliteal Lesions

Unmet Technical Needs and Opportunities for the Development of Next-Generation Technologies

DCB in BTK Intervention: Ongoing Trials and Future Perspectives

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content